What is the recommended treatment with N-acetylcysteine (NAC) infusion for a patient with deliberate self-harm involving yellow phosphorus rodenticide?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 19, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

NAC Infusion for Yellow Phosphorus Rodenticide Poisoning

N-acetylcysteine (NAC) should be administered to patients with acute liver failure from yellow phosphorus rodenticide poisoning, as it significantly improves survival and reduces mortality despite the absence of specific antidote for this toxin. 1, 2, 3

Evidence for NAC in Rodenticide-Induced Acute Liver Failure

Survival Benefits

  • NAC treatment demonstrates significant survival benefits in rodenticide poisoning, with pooled analysis of randomized controlled trials showing improved recovery rates (OR: 3.97; 95% CI: 1.69-9.30) and reduced mortality (OR: 0.25; 95% CI: 0.11-0.59). 3

  • Retrospective studies confirm this mortality reduction (OR: 0.34; 95% CI: 0.15-0.78), with real-world data from Indian tertiary care settings showing significantly higher survival rates in NAC-treated versus non-NAC groups (p ≤ 0.03). 2, 3

  • Case series report successful recovery in 2 out of 3 patients with rodenticide-induced acute liver failure treated with NAC, including one pregnant patient. 1

Mechanism and Rationale

  • NAC functions as a glutathione precursor and provides antioxidant effects that protect hepatocytes from oxidative damage caused by yellow phosphorus, similar to its mechanism in acetaminophen toxicity. 4, 5

  • The American Gastroenterological Association recommends NAC for acute liver failure regardless of etiology, with meta-analysis showing improvements in overall survival (76% vs 59%) and liver transplant-free survival (64% vs 26%) in non-acetaminophen related acute liver failure. 6, 4, 5

Treatment Protocol

Timing and Administration

  • Initiate NAC as early as possible after yellow phosphorus ingestion, as time lag ≥24 hours is a significant risk factor for mortality (RR: 3.479; 95% CI: 1.137-10.645). 2

  • NAC is most beneficial when started early in the disease course, particularly in patients with grades I-II hepatic encephalopathy. 4, 5

Dosing Considerations

  • Mean oral loading dose reported in rodenticide poisoning studies: 7580.95 ± 2204.29 mg, with maintenance dose of 3694.53 ± 2322.58 mg. 2

  • Standard intravenous NAC protocols for acute liver failure should be followed, with treatment duration extended based on clinical response and liver function parameters. 4, 5

Safety Profile

  • NAC demonstrates excellent safety, with 93.4% of patients experiencing no adverse effects in rodenticide poisoning studies. 2

  • Common side effects include nausea, vomiting, skin rash (<5%), and transient bronchospasm (1-2%). 4, 5

Critical Management Points

Risk Stratification

  • Yellow phosphorus poisoning itself is a significant risk factor for mortality (RR: 2.888; 95% CI: 1.179-7.079), requiring aggressive early intervention. 2

  • Monitor for development of acute liver failure with serial liver function tests, coagulation studies (PT/INR), and hepatic encephalopathy grading. 7

Adjunctive Measures

  • Contact liver transplantation center immediately for all patients with severe yellow phosphorus poisoning and PT <50%, as transplantation remains the definitive treatment for severe intoxication. 7, 1, 8

  • Consider therapeutic plasma exchange (plasmapheresis) in severe cases, as it may remove the toxin, metabolites, and inflammatory mediators. 8

  • Maintain serum sodium 140-145 mmol/L, monitor glucose every 2 hours minimum, and provide multiorganic support as needed. 7

Monitoring Parameters

  • Serial assessment of hepatic encephalopathy grade (determines prognosis and NAC benefit). 5, 7

  • Apply King's College criteria or lactate levels for transplant evaluation: pH <7.3 after adequate volume resuscitation, or lactate >3.5 mmol/L at 4 hours or >3.0 mmol/L at 12 hours. 7

  • Track INR trends between days 3-4: rising INR associates with only 7% survival versus 79% if INR decreases. 7

Clinical Pitfalls to Avoid

  • Do not delay NAC administration while awaiting definitive diagnosis or transplant evaluation, as early treatment is critical for survival. 4, 2

  • Do not discontinue NAC prematurely; continue treatment for extended duration (potentially 3+ days) based on clinical response and liver function improvement. 2, 9

  • Recognize that yellow phosphorus poisoning has no specific antidote—NAC provides supportive hepatoprotection while awaiting potential transplantation or spontaneous recovery. 1, 8

References

Research

N-Acetyl Cysteine in Rodenticide Poisoning: A Systematic Review and Meta-Analysis.

Current reviews in clinical and experimental pharmacology, 2022

Guideline

Acetylcysteine Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Acetylcysteine for Viral Hepatitis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Tratamiento de la Falla Hepática Fulminante

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Related Questions

What is the recommended dosage of N-acetylcysteine (NAC) for an adult patient with deliberate self-harm involving yellow phosphorus rodenticide poisoning?
How to dilute N-acetylcysteine (NAC) in a patient with myocarditis secondary to rodenticide consumption, elevated Central Venous Pressure (CVP) indicating potential fluid overload, and risk of heart failure?
At what plasma paracetamol (acetaminophen) level is N-acetylcysteine (NAC) not necessary in cases of unknown ingestion time?
What are the effects of Ratol (Cholecalciferol) poisoning?
What is the treatment for yellow phosphorus poisoning?
What are the guidelines for screening and treating sarcoidosis in individuals with symptoms or a family history of the disease, particularly in high-risk ethnic groups such as African Americans or Europeans?
What is the treatment for a patient with deliberate self-harm involving yellow phosphorus rodenticide?
Should a patient with a history of atrial fibrillation (a fib) continue taking apixaban (eliquis) after undergoing ablation?
What is the best management approach for a patient with End-Stage Renal Disease (ESRD) on regular Hemodialysis, presenting with hyperkalemia and hyperphosphatemia, and also experiencing symptoms of Restless Leg Syndrome (RLS)?
What is the recommended dosage of N-acetylcysteine (NAC) for an adult patient with deliberate self-harm involving yellow phosphorus rodenticide poisoning?
In what situations is the use of theophyllines (methylxanthines) indicated for patients with chronic obstructive pulmonary disease (COPD)?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.